The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
As the Q1 earnings season continues, Seeking Alpha has published the transcript of Addex Therapeutics Ltd's Q1 2026 earnings call. The transcript allows investors to review the company's financial performance and management's strategic commentary for the period.
Shares of ADXN closed at $6.00 on June 24, 2026, trading between $5.70 and $6.33 during the session. No major economic events directly tied to the stock were recorded in recent days. Investors will focus on any updates regarding development plans or funding that may emerge from the earnings call.
Sign in to access this content
Sign In